IMCD acquires European specialties distributor

By Simon Pitman

- Last updated on GMT

IMCD acquires European specialties distributor
Netherlands-based IMCD has confirmed that it has acquired speciality chemicals distributor Volex, as part of its strategy to expand its own distribution footprint in Europe.

The company signed an agreement to acquire 100% of the outstanding shares in Velox, a group of companies that is headquartered in Germany.

It has an extensive commercial network across Europe and its long-standing, and has expertise in the areas of plastics, composites and other specialty markets, complimenting IMCD existing portfolio.

Established in 1993, Velox currently employs 225 people across 18 countries and generated revenues of Euros 155 million, and an EBITDA of Euros 5.4 million in 2017.

"This acquisition enables IMCD to further strengthen its position as distributor of speciality plastics and additives. Our portfolios very well complement each other, and we expect to be able to create more value for our suppliers and customers," ​said Piet van der Slikke, CEO of IMCD.

Expansion in North America

The company has also been expanding in the Americas in recent years, having confirmed in August of 2017 that it is set to acquire the Canadian distributor Lomas.

The two companies are both present in the ingredients and specialty chemicals areas, which means that IMCD will be able to significantly expand its footprint in both the Canadian and US markets.

IMCD acquired the business because it is an “excellent fit” with its own business model, with the benefits and synergies expected to have an immediate positive effect on the company’s bottom line.

IMCD builds on personal care operations

Earlier in 2017, the company also announced that it had opened a laboratory equipped to deliver formulations, testing and more to clients in the US, as part of plans to expand in the region.

IMCD opened what is the company’s 30th facility in its “network of global laboratories and technical centres of excellence,” ​​as the specialty chemical company told Cosmetics Design by email, at the time of the transaction.

The new IMCD lab is up and running in Miami, Florida. At a ceremony celebrating the new facility, Marcus Jordan, president of IMCD US Holdings remarked, “IMCD is delighted to launch its first application laboratory in the United States.”​​

Related news

Show more

Related products

show more

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 24-Apr-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers

Follow us


View more



Beauty 4.0 Podcast